Data / Form D filings / Areteia Therapeutics, Inc.
Areteia Therapeutics, Inc.: Form D filings
Areteia Therapeutics, Inc., a biotechnology company in Chapel Hill, NC, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on February 21, 2025, reports $360 million sold of a $445 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 GLEN LENNOX DR., SUITE 300, Chapel Hill, NC, 27517
- Phone
- (617) 504-0362
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1937542
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | Amendment | $445,000,000 | $360,000,020 | $84,999,980 | 16 | Jun 15, 2022 | sec.gov |
| Feb 22, 2024 | Amendment | $445,000,000 | $275,000,000 | $170,000,000 | 13 | Jun 15, 2022 | sec.gov |
| Jul 14, 2022 | New notice | $350,000,000 | $175,000,000 | $175,000,000 | 10 | Jun 15, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Benjamin Gomez | Director | |
| Adam Koppel | Director | |
| Ian Read | Director | |
| Michael E. Bozik | Director | |
| Daniel E. Becker | Director | |
| Robin E. Walker | Executive Officer | |
| Paul Berns | Director | |
| Christopher E. Courts | Executive Officer | |
| Stephen E. Butts | Director | |
| Jorge E. Bartolome | Executive Officer, Director | |
| Elyse E. Stock | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Feb 17, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Areteia Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.